IL182792A0 - Pharmaceutical compositions containing gepirone - Google Patents
Pharmaceutical compositions containing gepironeInfo
- Publication number
- IL182792A0 IL182792A0 IL182792A IL18279207A IL182792A0 IL 182792 A0 IL182792 A0 IL 182792A0 IL 182792 A IL182792 A IL 182792A IL 18279207 A IL18279207 A IL 18279207A IL 182792 A0 IL182792 A0 IL 182792A0
- Authority
- IL
- Israel
- Prior art keywords
- gepirone
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- containing gepirone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/032785 WO2006052227A1 (en) | 2004-11-05 | 2004-11-05 | High-dosage extended-release formulation of gepirone |
Publications (1)
Publication Number | Publication Date |
---|---|
IL182792A0 true IL182792A0 (en) | 2007-08-19 |
Family
ID=36336794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL182792A IL182792A0 (en) | 2004-11-05 | 2007-04-26 | Pharmaceutical compositions containing gepirone |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1809255A4 (en) |
JP (1) | JP2008519071A (en) |
CN (1) | CN101076320A (en) |
AU (1) | AU2004324868B2 (en) |
BR (1) | BRPI0419179A (en) |
CA (1) | CA2585606A1 (en) |
EA (1) | EA013213B1 (en) |
IL (1) | IL182792A0 (en) |
MX (1) | MX2007005368A (en) |
NO (1) | NO20072851L (en) |
WO (1) | WO2006052227A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20131906A1 (en) * | 2013-11-18 | 2015-05-19 | Gnosis Spa | ORAL SOLID COMPOSITIONS WITH SLOW RELEASE |
RU2713725C1 (en) * | 2019-02-08 | 2020-02-06 | Юрий Владимирович Соколов | Biologically active additive and method of its application |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
US5478572A (en) * | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
US6534507B1 (en) * | 1999-12-20 | 2003-03-18 | Fabre-Kramer Pharmaceuticals, Inc. | Methods for treating psychological disorders using bioactive metabolites of gepirone |
AU2002226371A1 (en) * | 2000-12-08 | 2002-06-18 | Akzo Nobel N.V. | Oral extended release formulation of gepirone |
US20030220346A1 (en) * | 2000-12-18 | 2003-11-27 | Kramer Stephen J. | Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
-
2004
- 2004-11-05 EA EA200701010A patent/EA013213B1/en not_active IP Right Cessation
- 2004-11-05 CA CA002585606A patent/CA2585606A1/en not_active Abandoned
- 2004-11-05 JP JP2007540289A patent/JP2008519071A/en active Pending
- 2004-11-05 BR BRPI0419179-0A patent/BRPI0419179A/en not_active Application Discontinuation
- 2004-11-05 EP EP04800476A patent/EP1809255A4/en not_active Withdrawn
- 2004-11-05 MX MX2007005368A patent/MX2007005368A/en not_active Application Discontinuation
- 2004-11-05 WO PCT/US2004/032785 patent/WO2006052227A1/en active Application Filing
- 2004-11-05 AU AU2004324868A patent/AU2004324868B2/en not_active Expired - Fee Related
- 2004-11-05 CN CNA2004800445809A patent/CN101076320A/en active Pending
-
2007
- 2007-04-26 IL IL182792A patent/IL182792A0/en unknown
- 2007-06-05 NO NO20072851A patent/NO20072851L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1809255A4 (en) | 2011-08-03 |
JP2008519071A (en) | 2008-06-05 |
EA013213B1 (en) | 2010-04-30 |
AU2004324868A1 (en) | 2006-05-18 |
EP1809255A1 (en) | 2007-07-25 |
EA200701010A1 (en) | 2007-10-26 |
MX2007005368A (en) | 2007-09-11 |
CN101076320A (en) | 2007-11-21 |
WO2006052227A1 (en) | 2006-05-18 |
CA2585606A1 (en) | 2006-05-18 |
AU2004324868B2 (en) | 2010-04-29 |
BRPI0419179A (en) | 2007-12-18 |
NO20072851L (en) | 2007-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL238308B (en) | Pharmaceutical compositions containing azelastine | |
IL223545A0 (en) | Pharmaceutical compositions | |
IL179809A0 (en) | Pharmaceutical compositions | |
GB0408308D0 (en) | Pharmaceutical compositions | |
IL177480A0 (en) | Pharmaceutical composition | |
IL179933A0 (en) | Pharmaceutical compositions containing proteosome based compositions | |
EP1729744A4 (en) | Pharmaceutical formulations | |
IL183986A0 (en) | Pharmaceutical compounds and compositions | |
IL187748A0 (en) | Pharmaceutical compositions containing misoprostal | |
EP1747004A4 (en) | Pharmaceutical compositions for metabolic insufficiences | |
GB0405033D0 (en) | Novel pharmaceutical compositions | |
GB0406378D0 (en) | Novel pharmaceutical compositions | |
PL1837019T3 (en) | Orally-dispersible pharmaceutical compositions | |
HU0401177D0 (en) | Pharmaceutical composition | |
GB0406380D0 (en) | Novel pharmaceutical compositions | |
PT2474528E (en) | Antineoplasic compounds and pharmaceutical compositions thereof | |
GB2411355B (en) | Pharmaceutical composition | |
GB0423800D0 (en) | New pharmaceutical formulations | |
EP1805154A4 (en) | Pharmaceutical compositions | |
ZA200701932B (en) | Pharmaceutical composition | |
GB0425255D0 (en) | Pharmaceutical composition | |
ZA200701931B (en) | Pharmaceutical composition | |
IL182792A0 (en) | Pharmaceutical compositions containing gepirone | |
HUP0401176A2 (en) | Pharmaceutical composition having prpkinetic effect | |
GB0407351D0 (en) | Pharmaceutical compositions |